Su Zhen 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 1, 2023
Insider Transaction Report
Form 4
Su Zhen
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2023-08-31+68,000→ 68,000 totalExercise: $1.28Exp: 2033-08-30→ Common Stock (68,000 underlying)
Footnotes (1)
- [F1]This option was granted on August 31, 2023. The shares underlying the option vest as to one-third (1/3) of the shares on August 31, 2024 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.